Nektar Therapeutics reports Q1 2026 financial results
Filed May 7, 2026 · Period ending May 7, 2026 · ~1 min read
Key Changes
-
high
Nektar announced first quarter 2026 financial results via press release on May 7, 2026. Actual revenue, earnings, cash position, and pipeline updates are in the attached press release, not the 8-K itself.
Item 2.02 verify on EDGAR → -
medium
This is a standard quarterly earnings disclosure. Investors should review the full press release (Exhibit 99.1) for financial details and any forward guidance provided by management.
8-K: Earnings verify on EDGAR →
See the full narrative summary and section-by-section diff — create a free account to read more. Takes 30 seconds.
Partner
Trade NKTR commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 8, 2026 4:10 PM